The injection port market comprises medical devices used for intravenous or intra-arterial administration of drugs, fluids, nutrients, or blood products in a controlled, efficient, and painless manner. Injection ports feature self-sealing septums that allow for multiple access points without additional needle sticks. They are predominantly used in hospital settings for patients undergoing chemotherapy, total parenteral nutrition, antibiotic therapy, blood transfusion, and post-surgical care. The rising incidence of cancer and chronic diseases is driving the demand for long-term treatment therapies requiring repeated drug administration, boosting the injection port market. Global Injection Port Market is estimated to be valued at US$ 1.57 Bn in 2024 and is expected to exhibit a CAGR of 7.6% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the injection port market are Jungbunzlauer, Gadot Biochemical Industries, Sucroal, Dr. Paul Lohmann, Global Calcium, TATE & LYLE, American Elements, Triveni Chemicals, A.B. Enterprises, Nikunj Chemicals, Advait Industries, Anmol Chemicals, Krishna Chemicals, AMS biotechnology, Henan Honghui Biotechnology. The growth of the market is driven by increasing prevalence of chronic diseases & cancer cases globally. Technological advancements are also supplementing the injection port market growth, with development of wearable and wireless injection ports improving patient comfort and convenience.
Market Trends
Some key trends witnessed in the injection port market include the development of needleless injection ports to entirely prevent needlestick injuries. This has gained significant popularity among healthcare providers. Another prominent trend is the advent of self-priming injection ports incorporating one-way valves and self-contained fluid pathways to facilitate quick priming without using an external syringe. This eliminates delays and reduces the risk of contamination.
Market Opportunities
The injection port market is expected to gain lucrative opportunities from growing demand for home healthcare products as more patients prefer medical treatments at home. This has spurred innovative product development by manufacturers to cater to home infusion needs. Additionally, expanding application scope of injection ports in pain management and chronic disease treatment is anticipated to create new avenues for market growth over the forecast period.
Injection Port Market Impact of COVID-19
The COVID-19 pandemic has significantly impacted the growth of the injection port market. During the initial lockdowns imposed across various countries, the production and supply chain activities were disrupted. This led to a decline in the demand for injection ports from end-use industries such as pharmaceuticals, chemicals and food & beverages. As many manufacturing units were temporarily shut down, the need for new injection ports reduced significantly.
However, as the restrictions were gradually lifted, the market started recovering. The demand increased from the pharmaceutical industry as more drugs and vaccines were being produced to fight COVID-19. Many new injection port designs were developed to ensure safe handling and transport of vaccines and therapeutics. The food & beverage industry also witnessed growing demand for injection ports for packaging various food products.
As the pandemic continues, companies in the injection port market are focusing on developing advanced injection ports with enhanced safety and anti-counterfeiting features. Attention is being given to produce single-use and disposable injection ports to minimize risks of contamination. Partnerships between injection port manufacturers and pharmaceutical companies have strengthened to address the rising need for medical injection systems. The demand from healthcare and lifesciences sectors is expected to remain high in the post-pandemic period as well.
Injection Port Market Geographical Regions
In terms of value, North America holds the largest share in the global injection port market, followed by Europe and Asia Pacific. The United States accounts for the majority demand for injection ports due to large pharmaceutical manufacturing base and growing healthcare spending.
Asia Pacific is projected to be the fastest-growing region during the forecast period. This can be attributed to expanding pharmaceutical, chemicals and food processing industries in China and India. Countries like China, India and South Korea are witnessing significant investments in setting up new manufacturing plants. This is generating high requirement for quality injection ports in the region.
Governments of various Asia Pacific countries are also taking initiatives to strengthen their domestic healthcare infrastructure and boost local drug production. This is expected to further propel the demand for injection ports from 2024 onwards in the Asia Pacific region.
